Who invested in Alphina Therapeutics?
Alphina Therapeutics's investors include Canaan, Connecticut Innovations and Alexandria Venture Investments.

United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$40Mraised across 2 rounds since 2021, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $154K sold, first sale Feb 2026
Source recordedSEC filing: $17M sold, first sale Sept 2021
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Alphina Therapeutics's investors include Canaan, Connecticut Innovations and Alexandria Venture Investments.
Alphina Therapeutics has raised $40M across 2 rounds since 2021.
Alphina Therapeutics's most recent round, $154K, was in Feb 2026.
Alphina Therapeutics's largest round on record is $40M (Series A), in Sept 2021.
Alphina Therapeutics's first round on record, in Sept 2021, was backed by Canaan, Connecticut Innovations and Alexandria Venture Investments.
Alphina Therapeutics's latest named round is a Series A, in Sept 2021.
Alphina Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.